original ) (raw )Association of the FDA Amendment Act with trial registration, publication, and outcome reporting
Jennifer Miller
Trials, 2017
View PDFchevron_right
Clinical Trials: The Role of Regulatory Agencies, Pharmacovigilance Laws, Guidelines, Risk Management, Patenting, and Publicizing Results
Sabitha Kandi
Borneo Journal of Pharmacy, 2023
View PDFchevron_right
Measuring clinical trial transparency: an empirical analysis of newly approved drugs and large pharmaceutical companies
Jennifer Miller
BMJ open, 2017
View PDFchevron_right
Clinical Trial Evidence Supporting FDA Approval of Novel Therapeutic Agents, 2005-2012
Jenerius Aminawung
JAMA, 2014
View PDFchevron_right
FDAAA legislation is working, but methodological flaws undermine the reliability of clinical trials: a cross-sectional study
Douglas Henrique Marin dos Santos
View PDFchevron_right
Clinical trials information in drug development and regulation
Bert de Brock
The annual research report, 2012
View PDFchevron_right
Reporting Bias in Drug Trials Submitted to the Food and Drug Administration: Review of Publication and Presentation
Kristin Rising
PLoS Medicine, 2008
View PDFchevron_right
Clinical trial transparency: a reassessment of industry compliance with clinical trial registration and reporting requirements in the United States
Jocelyn Ulrich
BMJ Open
View PDFchevron_right
The proposed rule for U.S. clinical trial registration and results submission
Jerry Sheehan
The New England journal of medicine, 2015
View PDFchevron_right
Making available information from studies sponsored by the pharmaceutical industry: some current practices
James Matcham
Pharmaceutical Statistics, 2011
View PDFchevron_right
Clinical Trials of New Drug Products: What Gets Compared to Whom
Charles Kowalski
American Journal of Clinical and Experimental Medicine, 2015
View PDFchevron_right
Commitments by the biopharmaceutical industry to clinical trial transparency: the evolving environment
Chris Winchester
BMJ Evidence-Based Medicine
View PDFchevron_right
Drug Registries and Approval of Drugs: Promises, Placebo, or a Real Success?
Peter Mol
Clinical therapeutics, 2018
View PDFchevron_right
ClinicalTrials.gov: An Underutilized Source of Research Data About the Design and Conduct of Commercial Clinical Trials
Jeffrey DiFrancesco
Therapeutic Innovation & Regulatory Science, 2015
View PDFchevron_right
Postmarket studies required by the US Food and Drug Administration for new drugs and biologics approved between 2009 and 2012: cross sectional analysis
Jennifer Miller
BMJ (Clinical research ed.), 2018
View PDFchevron_right
Scarce quality assurance documentation in major clinical trial registries for approved medicines used in post-marketing clinical trials
Julius Mugwagwa
Trials
View PDFchevron_right
Clinical Trials in New Drug Development
Theo Hoofwijk
Journal of Clinical Hypertension, 2013
View PDFchevron_right
Importance and Challenges of Studying Marketed Drugs: What Is a Phase IV Study? Common Clinical Research Designs, Registries, and Self-Reporting Systems
Stephen Glasser
The Journal of Clinical Pharmacology, 2007
View PDFchevron_right
FDA and Clinical Drug Trials: A Short History
Suzanne Junod
A Quick Guide to Clinical Trials, 2008
View PDFchevron_right
Analysis of FDA Novel Drug Approvals
Rekha Mehani
Biomedical and Pharmacology Journal, 2021
View PDFchevron_right
Contemplation on new drug approvals by U.S. FDA, 2011-2015
pavan Panchal
International Journal of Basic and Clinical Pharmacology, 2016
View PDFchevron_right
Regulatory Review of Novel Therapeutics — Comparison of Three Regulatory Agencies
Jenerius Aminawung
New England Journal of Medicine, 2012
View PDFchevron_right
Design and regulation of clinical trials; from the laboratory to the pharmacy
Okafor CN , Texila International Journal , ekenechukwu young
View PDFchevron_right
The potential for bias in reporting of industry-sponsored clinical trials
James Matcham
Pharmaceutical Statistics, 2011
View PDFchevron_right
A Taxpayer-Funded Clinical Trials Registry and Results Database
Erick Turner
PLoS Medicine, 2004
View PDFchevron_right
Regulatory overview on New Drugs and Clinical Trials Rules, 2019
Neha Meshram
International Journal of Drug Regulatory Affairs
View PDFchevron_right
Postmarketing commitments for novel drugs and biologics approved by the US Food and Drug Administration: a cross-sectional analysis
Jennifer Miller
BMC Medicine, 2019
View PDFchevron_right
Timing and Completeness of Trial Results Posted at ClinicalTrials.gov and Published in Journals
Romana Haneef
PLoS Medicine, 2013
View PDFchevron_right
Are results from pharmaceutical-company-sponsored studies available to the public?
Rafael Dal-Ré
European Journal of Clinical Pharmacology, 2010
View PDFchevron_right
Analysis of randomized clinical trials leading to new drug approvals in India and USA
Madhura Naik
International Journal of Clinical Trials, 2016
View PDFchevron_right
Clinical trial registration and reporting: a survey of academic organizations in the United States
Audrey Omar
BMC medicine, 2018
View PDFchevron_right